Ignite Creation Date:
2024-05-06 @ 3:09 PM
Last Modification Date:
2024-10-26 @ 1:43 PM
Study NCT ID:
NCT04535609
Status:
COMPLETED
Last Update Posted:
2024-05-08
First Post:
2020-08-27
Brief Title:
An Efficacy and Safety Study of 24 Week Treatment With Mavodelpar REN001 in Primary Mitochondrial Myopathy Patients
Sponsor:
Reneo Pharma Ltd
Organization:
Reneo Pharma Ltd
Organization Data
Organization:
Reneo Pharma Ltd
Class:
INDUSTRY
Study ID:
REN001-201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Reneo Pharma Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None